n an 18-month trial 1800 people in the early stages of Alzheimer’s were given the drug Lecanemab
I’m Matt Rosser with news that a new drug has been hailed for its ability to slow the pace of brain decline caused by Alzheimer’s disease. In an 18-month trial 1800 people in the early stages of Alzheimer’s were given the drug Lecanemab. Scientists found the pace of their cognitive decline had been reduced by 27 per cent when compared with people given a placebo. The results have not yet been subjected to full scientific scrutiny but the charity Alzheimer's Research says it’s ‘the news we’ve all been waiting for’. There are more than 140 experimental Alzheimer’s drugs in clinical testing at the moment. For more care related news stay with us here at Care Radio.
Archbishop calls for society wide shift in support for unpaid carers
Adult social care workers urged to share Covid stories
Young Carers missing out on carer's allowance
20% increase in those at risk from type 2 diabetes
Black and ethnic minority people are underrepresented in virtual patient cohorts.
NHS dental treatment has still not returned to pre-pandemic levels
London councils object to relocation of specialist cancer service
West Lothian Council workers could trigger a summer of strike action
Care UK in Portsmouth to remember the hundreds of thousands of those who took part in D-Day
NHS and social care leaders could save £1 billion annually by adopting an AI-led home healthcare model
Software to reduce hospital waiting times will be rolled out across Scotland over the next year
No money for carers to get free public transport in Suffolk
Carer's Allowance overpayments affecting five thousand people in Northern Ireland
Information about insect bites and stings surges ahead of this bank holiday weekend
Skinny jabs like Ozempic are being used as a cop-out